These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30441940)

  • 1. Celiac disease in children and adolescents.
    Frühauf P; Nabil El-Lababidi N; Szitányi P
    Cas Lek Cesk; 2018; 157(3):117-121. PubMed ID: 30441940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celiac disease without villous atrophy in children: a prospective study.
    Kurppa K; Ashorn M; Iltanen S; Koskinen LL; Saavalainen P; Koskinen O; Mäki M; Kaukinen K
    J Pediatr; 2010 Sep; 157(3):373-80, 380.e1. PubMed ID: 20400102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.
    Lindfors K; Rauhavirta T; Stenman S; Mäki M; Kaukinen K
    Exp Biol Med (Maywood); 2012 Feb; 237(2):119-25. PubMed ID: 22282398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring nonresponsive patients who have celiac disease.
    Krauss N; Schuppan D
    Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.
    Kurppa K; Collin P; Viljamaa M; Haimila K; Saavalainen P; Partanen J; Laurila K; Huhtala H; Paasikivi K; Mäki M; Kaukinen K
    Gastroenterology; 2009 Mar; 136(3):816-23. PubMed ID: 19111551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
    Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
    J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future treatment strategies for celiac disease.
    Lindfors K; Lähdeaho ML; Kalliokoski S; Kurppa K; Collin P; Mäki M; Kaukinen K
    Expert Opin Ther Targets; 2012 Jul; 16(7):665-75. PubMed ID: 22620264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiac disease: risk assessment, diagnosis, and monitoring.
    Setty M; Hormaza L; Guandalini S
    Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small bowel villous atrophy: celiac disease and beyond.
    Elli L; Branchi F; Sidhu R; Guandalini S; Assiri A; Rinawi F; Shamir R; Das P; Makharia GK
    Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):125-138. PubMed ID: 28000520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiac disease.
    Rossi T
    Adolesc Med Clin; 2004 Feb; 15(1):91-103, ix. PubMed ID: 15272258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Celiac disease--the chameleon among the food intolerances].
    Ströhle A; Wolters M; Hahn A
    Med Monatsschr Pharm; 2013 Oct; 36(10):369-80; quiz 381-2. PubMed ID: 24266248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Refractory celiac disease].
    Iwańczak F; Iwańczak B
    Pol Merkur Lekarski; 2013 Jul; 35(205):47-50. PubMed ID: 23984606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists.
    Collin P; Reunala T
    Am J Clin Dermatol; 2003; 4(1):13-20. PubMed ID: 12477369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gluten-free diet and quality of life in patients with screen-detected celiac disease.
    Mustalahti K; Lohiniemi S; Collin P; Vuolteenaho N; Laippala P; Mäki M
    Eff Clin Pract; 2002; 5(3):105-13. PubMed ID: 12088289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coeliac disease--a diagnostic and therapeutic challenge.
    Kaukinen K; Lindfors K; Collin P; Koskinen O; Mäki M
    Clin Chem Lab Med; 2010 Sep; 48(9):1205-16. PubMed ID: 20578966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review and practice guidelines for celiac disease in 2014.
    Nadhem ON; Azeez G; Smalligan RD; Urban S
    Postgrad Med; 2015 Apr; 127(3):259-65. PubMed ID: 25702766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.
    Murray JA; Kelly CP; Green PHR; Marcantonio A; Wu TT; Mäki M; Adelman DC;
    Gastroenterology; 2017 Mar; 152(4):787-798.e2. PubMed ID: 27864127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celiac disease: diagnosis and management.
    Pelkowski TD; Viera AJ
    Am Fam Physician; 2014 Jan; 89(2):99-105. PubMed ID: 24444577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Celiac disease--a diagnostic and therapeutic challenge].
    Kaukinen K; Collin P; Mäki M
    Duodecim; 2010; 126(3):245-54. PubMed ID: 20402035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.